Although, CX3CL1 additionally has tumor-suppressive activity as CX3CL1 overexpression has been shown to increase the chemotactic efficiency and infiltration of immune effector cell, resulting in an improved prognosis. The gene discussed is CX3CL1; the disease is neoplasm.